Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data

Journal of Neurosurgery

Volumn 98, Issue 1 SUPPL., 2003, Pages 74-81

  Herminghaus, Sebastian ^a,b,c,d   Dierks, Thomas ^a,b,c,d   Pilatus, Ulrich ^a,b,c,d   Möller Hartmann, Walter ^a,b,c,d   Wittsack, Jörg ^a,b,c,d   Marquardt, Gerhard ^a,b,c,d   Labisch, Christoph ^a,b,c,d   Lanfermann, Heinrich ^a,b,c,d   Schlote, Wolfgang ^a,b,c,d   Zanella, Friedhelm E ^a,b,c,d  

^a GOETHE UNIVERSITY   (Germany)

^b Neurological Institute (Edinger Institute)   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Brain neoplasm; Grading system; Magnetic resonance spectroscopy; Neuroepithelial brain tumor; Spectral pattern analysis

Indexed keywords

ACCURACY; ARTICLE; CANCER GRADING; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DISCRIMINANT ANALYSIS; FOLLOW UP; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; NEUROEPITHELIOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SPECTRUM; TUMOR BIOPSY; TUMOR DIAGNOSIS; WORLD HEALTH ORGANIZATION;

EID: 0037222646     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.1.0074     Document Type: Article

References (67)

1. Alger JR, Frank JA, Bizzi A, et al: Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633-641, 1990
2. Arnold DL, Shoubridge EA, Villemure JG, et al: Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading. NMR Biomed 3:184-189, 1990
3. Aronen HJ, Gazit IE, Louis DN, et al: Cerebral blood volume maps of gliomas: Comparison with tumor grade and histological findings. Radiology 191:41-51, 1994
4. Begg CB: Statistical methods in medical diagnosis. Crit Rev Med Inform 1:1-22, 1986
5. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333-348, 1987
6. Brant-Zawadzki M: Pitfalls of contrast-enhanced imaging in the nervous system. Magn Reson Med 22:243-248, 1991
7. Cabanas ME: MRUI: Magnetic Resonance User Interface. (http://www.mrui.uab.es/mrui/mruiHomePage.html) [Accessed 4 November 2002]
8. Carapella CM, Carpinelli G, Knijn A, et al: Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours. Acta Neurochir Suppl 68:127-132, 1997
9. Castillo M, Smith JK, Kwock L, et al: Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR 22:60-64, 2001
10. Cecconi L, Pompili A, Caroli F: MRI Atlas of Central Nervous System Tumors. New York: Springer, 1992. pp 95-135
11. Condon B, Chumas P, Oluoch-Olunya D, et al: Early 1H MRS changes in peritumoural oedema following the administration of dexamethasone. Proc Int Soc Magn Reson Med 4:550, 1995 (Abstract)
12. Dean BL, Drayer BP, Bird CR, et al: Gliomas: Classification with MR imaging. Radiology 174:411-415, 1990
13. Di Chiro G: Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 22:360-371, 1987
14. Florian CL, Preece NE, Bhakoo KK, et al: Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed 8:253-264, 1995
15. Fulham MJ, Bizzi A, Dietz MJ, et al: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology 185:675-686, 1992
16. Furuya S, Naruse S, Ide M, et al: Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method. NMR Biomed 10:25-30, 1997
17. Gotsis ED, Fountas K, Kapsalaki E, et al: In vivo proton MR spectroscopy: The diagnostic possibilities of lipid resonances in brain tumors. Anticancer Res 16:1565-1567, 1996
18. Haase A, Frahm J, Hänicke W, et al: 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 30:341-344, 1985
19. Herholz K, Heindel W, Luyten PR, et al: In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 31:319-327, 1992
20. Hoshino T: A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 61:895-900, 1984
21. Howells SL, Maxwell RJ, Griffiths RJ: Classification of tumour 1H NMR spectra by pattern recognition. NMR Biomed 5:59-64, 1992
22. Howells SL, Maxwell RJ, Peet AC, et al: An investigation of tumor 1H nuclear magnetic resonance spectra by the application of chemometric techniques. Magn Reson Med 28:214-236, 1992
23. Just M, Thelen M: Tissue characterization with T1, T2, and proton density values: Results in 160 patients with brain tumors. Radiology 169:779-785, 1988
24. Källen K, Heiling M, Andersson AM, et al: Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: Comparison with conventional CT. AJNR 17:925-932, 1996
25. Kinoshita Y, Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10:2-12, 1997
26. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System. Berlin: Springer-Verlag, 1993
27. Klunk WE, Xu CJ, Panchalingam K, et al: Analysis of magnetic resonance spectra by mole percent: Comparison of absolute units. Neurobiol Aging 15:133-140, 1994
28. Komiyama M, Yagura H, Baba M, et al: MR imaging: Possibility of tissue characterization of brain tumors using T1 and T2 values. AJNR 8:65-70, 1987
29. Kondziolka D, Lunsford LD, Martinez AJ: Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533-536, 1993
30. Kuesel AC, Sutherland GR, Halliday W, et al: 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR Biomed 7:149-155, 1994
31. Kurki T, Lundbom N, Kalimo H, et al: MR classification of brain gliomas: Value of magnetization transfer and conventional imaging. Magn Reson Imaging 13:501-511, 1995
32. Lanfermann H, Kugel H, Heindel W, et al: Metabolic changes in acute and subacute cerebral infarctions: Findings at proton MR spectroscopic imaging. Radiology 196:203-210, 1995
33. Lazeyras F, Charles HC, Boyko O, et al: New perspectives in tumor grading by combined short echo/long echo 1H spectroscopic imaging. Soc Magn Reson Med 11:3604, 1992 (Abstract)
34. Leach MO: Introduction to in vivo MRS of cancer: New perspectives and open problems. Anticancer Res 16:1503-1514, 1996
35. Lin AP. Ross BD: Short-echo time proton MR spectroscopy in the presence of gadolinium. J Comput Assist Tomogr 25:705-712, 2001
36. Lowry OH, Berger SJ, Chi MM, et al: Diversity of metabolic patterns in human brain tumors-I. High energy phosphate compounds and basic composition. J Neurochem 29:959-977, 1977
37. Lüdemann L, Grieger W, Wurm R, et al: Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 11:1231-1241, 2001
38. Nadler JV, Cooper JR: N-acetyl-L-aspartic acid content of human neural tumors and bovine peripheral nervous tissues. J Neurochem 19:313-319, 1972
39. Negendank WG, Sauter R, Brown TR, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study. J Neurosurg 84:449-458, 1996
40. Nieder C, Nestle U: A review of current and future treatment strategies for malignant astrocytomas in adults. Strahlenther Onkol 176:251-258, 2000
41. Panel on discriminant analysis, classification, and clustering: Discriminant analysis and clustering. Stat Sci 4:34-69, 1989
42. Petroff OAC, Spencer DD, Alger JR, et al: High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 39:1197-1202, 1989
43. Pierallini A, Bonamini M, Osti MF, et al: Supratentorial glioblastoma: Neuroradiological findings and survival after surgery and radiotherapy. Neuroradiology 38 (Suppl 1):S26-S30, 1996
44. Pijnappel WWF, van den Boogart, de Beer R, et al: SVD-based quantification of magnetic resonance signals. J Magn Reson 97:122-134, 1992
45. Podo F: Tumor phospholipid metabolism. NMR Biomed 12:413-439, 1999
46. Preul MC, Caramanos Z, Collins DL, et al: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323-325, 1996
47. Ricci PE, Pitt A, Keller PJ, et al: Effect of voxel position on single-voxel MR spectroscopy findings. AJNR 21:367-374, 2000
48. Ruiz-Cabello J, Cohen JS: Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 5:226-233, 1992
49. Schiffer D: Brain Tumors: Biology, Pathology, and Clinical References, Ed 2. New York: Springer, 1997, pp 109-122
50. Schiffer D: Brain Tumors: Biology, Pathology, and Clinical References, Ed 2. New York: Springer, 1997, pp 150-155
51. Shimizu H, Kumabe T, Shirane R, et al: Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR 21:659-665, 2000
52. Smith JK, Kwock L, Castillo M: Effects of contrast material on single-volume proton MR spectroscopy. AJNR 21:1084-1089, 2000
53. Somorjai RL, Nikulin AE, Pizzi N, et al: Computerized consensus diagnosis: A classification strategy for the robust analysis of MR spectra. I. Application to 1H spectra of thyroid neoplasms. Magn Reson Med 33:257-263, 1995
54. Speck O, Thiel T, Bini W, et al: Grading and therapy monitoring of astrocytomas with 1H spectroscopy. Proc Int Soc Magn Reson Med 3:1716, 1995 (Abstract)
55. Stack JP, Antoun NM, Jenkins JPR, et al: Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain. Neuroradiology 30:145-154, 1988
56. StatSoft: Statistica Version ST 5.1: User-Handbook. Tulsa: StatSoft, 1999, p 1503
57. StatSoft: Statistica Version ST 5.1: User-Handbook. Tulsa: StatSoft, 1999, pp 3063-3101
58. Tate AR, Barton SJ, Howe F, et al: Automated classification of in vivo short echo time 1H spectra of human brain tumors from two different centers using principal component analysis. Proc Int Soc Magn Reson Med 7:1388, 1999 (Abstract)
59. Tate AR, Griffiths JR, Martinez-Perez I, et al: Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed 11:177-191, 1998
60. Tedeschi G, Lundbom N, Raman R, et al: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516-524, 1997
61. Usenius JP, Tuohimetsa S, Vainio P, et al: Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. Neuroreport 7:1597-1600, 1996
62. Usenius JP, Vainio P, Hernesniemi J, et al: Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 63:1538-1543, 1994
63. van den Veen JW, de Beer R, Luyten PR, et al: Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge. Magn Reson Med 6:92-98, 1988
64. Wallace JC, Raaphorst GP, Somorjai RL, et al: Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magn Reson Med 38:569-576, 1997
65. Wilken B, Dechent P, Herms J, et al: Quantitative proton magnetic resonance spectroscopy of focal brain lesions. Pediatr Neurol 23:22-31, 2000
66. Woesler B, Kuwert T, Morgenroth C, et al: Non-invasive grading of primary brain tumours: Results of a comparative study between SPET with 123I-alpha tyrosine and PET with 18F-deoxyglucose. Eur J Nucl Med 24:428-434, 1997
67. Ziegler A, von Kienlin M, Decorps M, et al: High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res 61:5595-5600, 2001